A legally contested executive order on foreign aid did, at least initially, halt the distribution of life-saving HIV drugs.
The new Secretary of State Marco Rubio's waiver ensures PEPFAR's vital HIV/AIDS relief continues despite Trump's aid freeze, but the exclusion of gender identity programs raises concerns.
Secretary of State Marco Rubio’s order to pause nearly all foreign aid has halted funding to the President’s Emergency Plan for AIDS Relief (PEPFAR), an African HIV-prevention program launched by President George W.
The President’s Emergency Plan for AIDS Relief (PEPFAR), a federal program that provides HIV medications, is one of the programs on pause during a 90-day review ordered by the Secretary of State.
A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left organizations uncertain.
U.S. Secretary of State Marco Rubio will allow access to HIV treatment for people in 55 countries worldwide funded by the U.S.
The United States Secretary of State, Marco Rubio, has approved an “Emergency Humanitarian Waiver”, which will allow people to continue accessing HIV treatment funded by the US across 55 countries worldwide.
The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future of PEPFAR, which has saved 25 million lives.
Secretary of State Marco Rubio backtracked on Trump’s near-total foreign aid freeze and approved potentially billions of dollars in “life-saving humanitarian assistance.” Many aid groups are still unsure what that means.
Officials inside and outside of the US government are grappling with the fallout of the Trump administration’s sudden suspension of almost all foreign aid with some humanitarian officials warning that people will die as a result.
It is estimated that PEPFAR supports treatment for over 20 million people living with HIV, accounting for two-thirds of all people globally receiving HIV treatment
Approximately 60 senior staff within USAID have been suspended, leaving the agency without clear leadership, five sources familiar with the internal action told CBS News.